Targeting CD33 in AML: Therapeutic Strategies With New Antibody –Drug Conjugates

Learning Module - In this interactive, CME-certified module, William Donnellan, MD, provides expert perspective on advances in CD33-targeted therapies for AML and discusses ongoing clinical trials.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research